Compare PD & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PD | OPK |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2019 | 1995 |
| Metric | PD | OPK |
|---|---|---|
| Price | $12.55 | $1.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $17.10 | $2.28 |
| AVG Volume (30 Days) | 1.6M | ★ 3.9M |
| Earning Date | 11-25-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | $489,207,000.00 | ★ $642,067,000.00 |
| Revenue This Year | $8.16 | N/A |
| Revenue Next Year | $3.88 | N/A |
| P/E Ratio | $7.77 | ★ N/A |
| Revenue Growth | ★ 7.01 | N/A |
| 52 Week Low | $11.13 | $1.11 |
| 52 Week High | $20.00 | $2.04 |
| Indicator | PD | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 58.69 |
| Support Level | $12.06 | $1.24 |
| Resistance Level | $12.77 | $1.33 |
| Average True Range (ATR) | 0.38 | 0.05 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 35.06 | 100.00 |
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.